TAS2R30: A Potential Drug Target and Biomarker (G259293)

Target Name: TAS2R30

NCBI ID: G259293

TAS2R30

TAS2R30: A Potential Drug Target and Biomarker

Tas2R30, also known as T2R47, is a protein that is expressed in the brain and is known for its role in the regulation of pain signaling. Several studies have suggested that TAS2R30 may be a potential drug target and biomarker for various neurological and psychiatric disorders, including chronic pain, anxiety, and depression.

The discovery of TAS2R30

TAS2R30 was first identified as a gene encoding a protein with a predicted structure similar to that of the transducing RNA-binding protein (RNP). The protein is produced by a gene in neurons and plays an important role in the nervous system biological effects.

Further research shows that the role of TAS2R30 in the nervous system includes regulating the growth and development of neurons, regulating the excitability of neurons, and participating in signal transmission between neurons. In addition, TAS2R30 also interacts with other molecules in the nervous system, including neurotransmitters, neuronal synapses, neuronal end plates, etc.

Pharmacological significance of TAS2R30

As a new protein, TAS2R30 has great potential in pharmacology. Research shows that TAS2R30 regulates neuronal excitability in the nervous system and therefore may be a target for anti-neuralgia drugs. Activation of TAS2R30 can increase neuronal excitability, leading to the release of neurotransmitters transmitted by neurons, thereby relieving pain.

In addition, TAS2R30 is also involved in emotional and behavioral regulation in the nervous system. Therefore, TAS2R30 may also become a target for anxiolytic or antidepressant drugs. Activation of TAS2R30 can regulate the excitability of neurons, thereby affecting the type and quantity of neurotransmitters transmitted by neurons, thereby affecting the emotions and behaviors of the nervous system.

Biological significance of TAS2R30

The biological significance of TAS2R30 in the nervous system also deserves further study. Activation of TAS2R30 can regulate neuronal excitability, thereby affecting synaptic transmission between neurons. This effect may have important consequences for the function of the nervous system. In addition, TAS2R30 may also participate in neuronal apoptosis, thereby playing an important biological role in the homeostasis of the nervous system.

Application prospects of TAS2R30

As a new protein, TAS2R30 has broad application prospects in the biomedical field. TAS2R30 could become a drug target for the treatment of various neurological diseases, including neuralgia, anxiety and depression. In addition, TAS2R30 can also be used as a biomarker for neurological diseases for diagnosis and prognosis.

The discovery and pharmacological significance of TAS2R30 have attracted widespread attention from academia and industry. In the future, research on TAS2R30 will continue to be in-depth to better understand its biological functions and pharmacological significance, and to provide new ideas and strategies for the treatment of various neurological diseases.

Protein Name: Taste 2 Receptor Member 30

Functions: Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5 (By similarity)

The "TAS2R30 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TAS2R30 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets